Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(32 sites)
United States
Honor Health Scottsdale Shea Medical Center, Scottsdale, Arizona El Centro Regional Medical Center, El Centro, California Jacob's Medical Center at UC San Diego Health, La Jolla, California Denver Health and Hospital Authority, Denver, Colorado Yale New Haven Hospital, New Haven, Connecticut Access Research Institute, Brooksville, Florida University of FL Health Heart and Vascular Hospital, Gainesville, Florida Mayo Clinic Florida, Jacksonville, Florida American Access Care of Miami, LLC, Miami, Florida USF Health South Tampa, Tampa, Florida Georgia Nephrology, Atlanta, Georgia Grady Memorial Hospital, Atlanta, Georgia IU Health Bloomington Hospital, Bloomington, Indiana John Hopkins University School of Medicine, Baltimore, Maryland Brigham and Women's Hospital, Boston, Massachusetts Boston Medical Center, Boston, Massachusetts University of Michigan, Ann Arbor, Michigan Rutgers University_Medical, Newark, New Jersey St.Joseph's University Medical Center, Paterson, New Jersey Capital Health Medical Center- Hopewell, Pennington, New Jersey New York-Presbyterian Queens_The Lang Center for Research & Education, Flushing, New York Ambulatory Care Pavilion Westchester Medical Center, Valhalla, New York Surgical Specialists of Charlotte, Charlotte, North Carolina Duke Regional Hospital, Durham, North Carolina Wake Forest University School of Medicine_Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina Temple University, Philadelphia, Pennsylvania University of Tennessee Medical Center, Knoxville, Tennessee Dell Seton Medical Center at The University of Texas at Austin, Austin, Texas Dr. Ruben Villa__Nephrology, Lubbock, Texas Cataract & Surgery Center Lubbock, Lubbock, Texas San Antonio Vascular and Endovascular Clinic PLLC, San Antonio, Texas The San Antonio Vascular and Endovascular Clinic, San Antonio, Texas